Related Experiment Video

Updated: Mar 2, 2026

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

8.1K

Antibody-Drug Conjugates for Cancer Therapy

Adam C Parslow1,2, Sagun Parakh3,4,5, Fook-Thean Lee6

  • 1Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria 3084, Australia. adam.parslow@onjcri.org.au.

Biomedicines
|May 25, 2017
PubMed

Insights

Antibody-drug conjugates (ADCs) offer targeted cancer therapy by linking antibodies to cytotoxic drugs. Optimizing ADC design and identifying resistance mechanisms are key to improving patient outcomes in cancer treatment.

Area of Science:

  • Oncology
  • Pharmacology
  • Biotechnology

Background:

  • Antibody-drug conjugates (ADCs) utilize monoclonal antibodies for targeted delivery of cytotoxic agents to tumor cells.
  • The development of ADCs presents significant opportunities for advancing cancer patient care.

Purpose of the Study:

  • To review critical factors influencing the clinical efficacy of ADCs in cancer therapy.
  • To identify strategies for enhancing patient outcomes with ADC treatments.

Main Methods:

  • Literature review of current research on antibody-drug conjugates.
  • Analysis of challenges in ADC design and optimization.
  • Exploration of patient selection and resistance mechanisms.

Main Results:

  • ADC technology offers targeted cancer treatment with potential for improved patient care.
  • Challenges persist in the design and optimization of ADC compounds.
  • Strategies for improving patient outcomes include enhanced patient selection and understanding therapy resistance.

Conclusions:

  • Antibody-drug conjugates are a promising therapeutic class in oncology.
  • Further research into ADC optimization and resistance mechanisms is crucial for clinical success.
  • Personalized treatment approaches and understanding resistance are vital for maximizing ADC benefits.
Keywords:
ADCantibody–drug conjugatecancerimmunotherapymonoclonal antibodiesresistance

More Related Videos

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

8.3K
In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research08:53

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on: September 16, 2019

9.7K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
3.2K